When is an aggressive evaluation and management strategy needed in patients with erysipelas?

Updated: Jun 14, 2019
  • Author: Thomas E Herchline, MD; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print
Answer

Patients who exhibit clinical deterioration or increasing toxicity require an aggressive evaluation and management strategy with antimicrobial therapy dependent on the results of Gram stain, culture, and drug-susceptibility analysis, if these are available. [2]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!